Vimarsana
Biggest News Aggregation in the World

Safer Technologies Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Safer Technologies Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Safer Technologies Program Today - Breaking & Trending Today

OtoNexus Medical Technologies Selected for Elite FDA STeP Program - Vimarsana News

OtoNexus Medical Technologies Selected for Elite FDA STeP Program

/PRNewswire/ -- OtoNexus Medical Technologies, the developer of the Novoscope ultrasound otoscope for immediate and automatic differentiation of bacterial...

FDA's Proposed Rule For Oversight Of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy – Key Considerations & Open Questions - Healthcare - Vimarsana News

FDA's Proposed Rule For Oversight Of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy – Key Considerations & Open Questions - Healthcare

After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs.

Source: mondaq.com
FDA's Proposed Rule for Oversight of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy - Key Considerations & Open Questions | Goodwin - Vimarsana News

FDA's Proposed Rule for Oversight of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy - Key Considerations & Open Questions | Goodwin

After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If...

UroMems completes first-in-man enrollment for smart implant study - Vimarsana News

UroMems completes first-in-man enrollment for smart implant study

UroMems announced today that it successfully completed enrollment in its first-in-human study of its UroActive system.

Smart implant from UroMems meets primary endpoint in study - Vimarsana News

Smart implant from UroMems meets primary endpoint in study

UroMems announced that it successfully met the primary endpoints for the initial male patient in a study of its UroActive smart implant.